![HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration - Ophthalmology HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration - Ophthalmology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/46810730-7a6d-4556-8d77-11f828e94a75/gr1ab_lrg.jpg)
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration - Ophthalmology
![Overview of clinical trials for dry age-related macular degeneration Cheng WS, Lu DW, Chiang CH, Chang CJ - J Med Sci Overview of clinical trials for dry age-related macular degeneration Cheng WS, Lu DW, Chiang CH, Chang CJ - J Med Sci](https://www.jmedscindmc.com/articles/2017/37/4/images/JMedSci_2017_37_4_121_213578_t8.jpg)
Overview of clinical trials for dry age-related macular degeneration Cheng WS, Lu DW, Chiang CH, Chang CJ - J Med Sci
![Emerging innovations in nano-enabled therapy against age-related macular degeneration: A paradigm shift - ScienceDirect Emerging innovations in nano-enabled therapy against age-related macular degeneration: A paradigm shift - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378517321003045-gr1.jpg)
Emerging innovations in nano-enabled therapy against age-related macular degeneration: A paradigm shift - ScienceDirect
![NIH launches first U.S. clinical trial of patient-derived stem cell therapy to replace dying cells in retina | National Institutes of Health (NIH) NIH launches first U.S. clinical trial of patient-derived stem cell therapy to replace dying cells in retina | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/news-events/news-releases/2019/20191216-iPSC.jpg)
NIH launches first U.S. clinical trial of patient-derived stem cell therapy to replace dying cells in retina | National Institutes of Health (NIH)
![Overview of clinical trials for dry age-related macular degeneration Cheng WS, Lu DW, Chiang CH, Chang CJ - J Med Sci Overview of clinical trials for dry age-related macular degeneration Cheng WS, Lu DW, Chiang CH, Chang CJ - J Med Sci](https://www.jmedscindmc.com/articles/2017/37/4/images/JMedSci_2017_37_4_121_213578_t7.jpg)
Overview of clinical trials for dry age-related macular degeneration Cheng WS, Lu DW, Chiang CH, Chang CJ - J Med Sci
![Global Burden of Dry Age-Related Macular Degeneration: A Targeted Literature Review - Clinical Therapeutics Global Burden of Dry Age-Related Macular Degeneration: A Targeted Literature Review - Clinical Therapeutics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f2e6450f-fef9-4523-a427-18f90eb11936/gr1_lrg.jpg)
Global Burden of Dry Age-Related Macular Degeneration: A Targeted Literature Review - Clinical Therapeutics
![Emerging therapies and their delivery for treating age‐related macular degeneration - Thomas - - British Journal of Pharmacology - Wiley Online Library Emerging therapies and their delivery for treating age‐related macular degeneration - Thomas - - British Journal of Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/5cf09127-1ec9-4085-92f4-f45012c9f627/bph15459-toc-0001-m.png)